---
input_text: 'Deferasirox in children with transfusion-dependent thalassemia or sickle
  cell anemia: A large cohort real-life experience from Turkey (REACH-THEM). OBJECTIVES:
  To evaluate the long-term efficacy and safety of deferasirox therapy in a large
  observational cohort of children with transfusion-dependent thalassemia (TDT) and
  sickle cell anemia (SCA) in Turkey. METHODS: This was a multicenter, prospective
  cohort study including TDT and SCA patients aged 2-18 years with iron overload (>=100
  mL/kg of pRBC or a serum ferritin [SF] level >1000 mug/L) receiving deferasirox.
  Patients were followed for up to 3 years according to standard practice. RESULTS:
  A total of 439 patients were evaluated (415 [94.5%] TDT, 143 [32.6%] between 2 and
  6 years). Serum ferritin levels consistently and significantly decreased across
  3 years of deferasirox therapy from a median of 1775.5 to 1250.5 mug/L (P < 0.001).
  Serum ferritin decreases were noted in TDT (1804.9 to 1241 mug/L), SCA (1655.5 to
  1260 mug/L), and across age groups of 2-6 years (1971.5 to 1499 mug/L), 7-12 years
  (1688.5 to 1159.8 mug/L), and 13-18 years (1496.5 to 1107 mug/L). Serum ferritin
  decreases were also noted for all deferasirox dose groups but only significant in
  patients with doses >=30 mg/kg/d (n = 120, -579.6 median reduction, P < 0.001).
  Only 9 (2%) patients had adverse events suspected to be related to deferasirox.
  Serum creatinine slightly increased but remained within the normal range. CONCLUSIONS:
  Deferasirox has long-term efficacy and safety in children with TDT and SCA, although
  higher doses (>=30 mg/kg/d) may be required to achieve iron balance.'
raw_completion_output: |-
  primary_disease: transfusion-dependent thalassemia (TDT) and sickle cell anemia (SCA)

  medical_actions: deferasirox therapy; monitoring serum ferritin levels; adjusting deferasirox dose

  symptoms: iron overload; increased serum ferritin levels

  chemicals: deferasirox

  action_annotation_relationships: deferasirox therapy TREATS iron overload IN transfusion-dependent thalassemia (TDT); deferasirox therapy TREATS iron overload IN sickle cell anemia (SCA); monitoring serum ferritin levels TREATS increased serum ferritin levels IN transfusion-dependent thalassemia (TDT); monitoring serum ferritin levels TREATS increased serum ferritin levels IN sickle cell anemia (SCA); adjusting deferasirox dose TREATS iron overload IN transfusion-dependent thalassemia (TDT); adjusting deferasirox dose TREATS iron overload IN sickle cell anemia (SCA)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  adjusting deferasirox dose TREATS iron overload IN sickle cell anemia (SCA)

  ===

extracted_object:
  primary_disease: MONDO:0020380
  medical_actions:
    - deferasirox therapy
    - monitoring serum ferritin levels
    - adjusting deferasirox dose
  symptoms:
    - iron overload
    - HP:0003281
  chemicals:
    - CHEBI:49005
  action_annotation_relationships:
    - subject: MAXO:0001298
      predicate: TREATS
      object: iron overload
      qualifier: transfusion-dependent thalassemia (TDT)
      subject_qualifier: deferasirox
      subject_extension: CHEBI:49005
    - subject: deferasirox therapy
      predicate: TREATS
      object: iron overload
      qualifier: MONDO:0020380
      subject_extension: CHEBI:49005
    - subject: <monitoring>
      predicate: <TREATS>
      object: <increased serum ferritin levels>
      qualifier: <transfusion-dependent thalassemia (TDT)>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <serum ferritin levels>
      object_extension: <serum ferritin levels>
    - subject: monitoring serum ferritin levels
      predicate: TREATS
      object: HP:0003281
      qualifier: MONDO:0020380
    - subject: adjusting deferasirox dose
      predicate: TREATS
      object: iron overload
      qualifier: transfusion-dependent thalassemia (TDT)
      subject_extension: CHEBI:49005
    - subject: adjusting deferasirox dose
      predicate: TREATS
      object: iron overload
      qualifier: MONDO:0011382
      subject_extension: CHEBI:49005
named_entities:
  - id: MAXO:0000756
    label: transfusion
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:35341
    label: steroids
  - id: CHEBI:81579
    label: erythropoietin
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MAXO:0001077
    label: splenectomy
  - id: MAXO:0001001
    label: gene therapy
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MONDO:0000984
    label: Thalassemia
  - id: HP:0001903
    label: anemia
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: HP:0001744
    label: splenomegaly
  - id: HP:0031274
    label: hypovolemic shock
  - id: CHEBI:44423
    label: hydroxyurea
  - id: MONDO:0007374
    label: Sickle Cell Disease (SCD)
  - id: MAXO:0001017
    label: Vaccination
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: HP:0001596
    label: hair loss
  - id: HP:0000789
    label: infertility
  - id: MAXO:0000647
    label: chemotherapy
  - id: MONDO:0000001
    label: disease
  - id: CHEBI:15422
    label: Adenosine triphosphate
  - id: CHEBI:19324
    label: 2,3-diphosphoglycerate
  - id: CHEBI:16856
    label: Glutathione
  - id: CHEBI:176783
    label: Vitamin C
  - id: MAXO:0010203
    label: Echocardiography
  - id: HP:0002870
    label: Obstructive sleep apnoea (OSA)
  - id: HP:0012531
    label: Pain
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: HP:0000112
    label: Kidney disease
  - id: HP:0012594
    label: Microalbuminuria
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003774
    label: End-stage renal disease
  - id: HP:0000716
    label: depression
  - id: HP:0000739
    label: anxiety
  - id: HP:0007760
    label: Sickle cell disease (SCD)
  - id: HP:0001875
    label: neutropenia
  - id: HP:0012234
    label: agranulocytosis
  - id: CHEBI:4356
    label: desferrioxamine (DFO)
  - id: CHEBI:17941
    label: deferiprone (DFP)
  - id: CHEBI:49005
    label: deferasirox (DFX)
  - id: CHEBI:9144
    label: silymarin
  - id: CHEBI:50453
    label: desferrioxamine
  - id: CHEBI:68554
    label: deferiprone
  - id: MONDO:0019402
    label: Thalassemia major
  - id: HP:0012532
    label: chronic pain
  - id: HP:0100639
    label: erectile dysfunction
  - id: CHEBI:71940
    label: Tadalafil
  - id: HP:0001297
    label: stroke
  - id: HP:0000083
    label: Renal failure
  - id: HP:0000488
    label: Retinopathy
  - id: HP:0001081
    label: Cholelithiasis
  - id: HP:0200023
    label: Priapism
  - id: MONDO:0044348
    label: Hemoglobinopathies
  - id: CHEBI:15551
    label: Prostaglandin E2
  - id: CHEBI:18248
    label: Iron
  - id: CHEBI:30660
    label: Thyroxine
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation
  - id: HP:0001923
    label: Hemolysis (reticulocytosis)
  - id: MAXO:0000068
    label: transplantation
  - id: CHEBI:16467
    label: arginine (Arg)
  - id: CHEBI:18211
    label: citrulline (Citr)
  - id: CHEBI:3638
    label: chloroquine
  - id: CHEBI:17929
    label: asymmetric dimethylarginine
  - id: MONDO:0800385
    label: Iron overload
  - id: CHEBI:6456
    label: Lidocaine
  - id: CHEBI:30413
    label: heme
  - id: MAXO:0000819
    label: Blood collection
  - id: MONDO:0013517
    label: beta-thalassemia
  - id: CHEBI:18050
    label: L-Glutamine
  - id: CHEBI:28901
    label: Busulfan
  - id: MONDO:0044753
    label: Lumbar spinal stenosis
  - id: HP:0001945
    label: Fever
  - id: HP:0002094
    label: Dyspnea
  - id: CHEBI:33281
    label: Antibiotics
  - id: HP:0006554
    label: Acute Liver Failure
  - id: HP:0001919
    label: Acute Kidney Injury
  - id: MONDO:0800198
    label: Antibodies of unknown specificity (AUS)
  - id: HP:0002289
    label: Antibodies of unknown specificity (AUS)
  - id: MAXO:0010033
    label: umbilical cord blood transplantation
  - id: CHEBI:16480
    label: Nitric Oxide
  - id: CHEBI:65308
    label: S-nitrosothiol (SNO)
  - id: CHEBI:17334
    label: Penicillin
  - id: HP:0003287
    label: Mitochondrial dysfunction
  - id: HP:0025464
    label: Oxidative stress
  - id: CHEBI:17287
    label: Phosphocreatine
  - id: CHEBI:24838
    label: Inorganic phosphate
  - id: CHEBI:27226
    label: Uric acid
  - id: CHEBI:50443
    label: hematopoietic stem cell (HSC) transplantation
  - id: CHEBI:32599
    label: magnesium sulphate
  - id: CHEBI:25107
    label: magnesium
  - id: MAXO:0000601
    label: Dialysis
  - id: HP:0100820
    label: Glomerulopathy
  - id: HP:0000790
    label: Hematuria
  - id: HP:0001635
    label: heart failure
  - id: HP:0100543
    label: Cognitive deficits
  - id: MONDO:0004979
    label: Asthma
  - id: CHEBI:119915
    label: fentanyl
  - id: CHEBI:29016
    label: arginine
  - id: MAXO:0000618
    label: Fluid replacement therapy
  - id: CHEBI:35480
    label: analgesics
  - id: CHEBI:135949
    label: Ambrisentan
  - id: CHEBI:80240
    label: Endothelin-1
  - id: MONDO:0003778
    label: primary immunodeficiencies
  - id: HP:0032148
    label: Episodic pain
  - id: MONDO:0005328
    label: Eye disease
  - id: MONDO:0020380
    label: pediatric sickle cell anemia (SCA)
  - id: CHEBI:35143
    label: hemoglobin (Hb)
  - id: CHEBI:125354
    label: Plerixafor
  - id: HP:0002204
    label: Pulmonary embolism
  - id: HP:0003270
    label: Abdominal distension
  - id: HP:0002027
    label: Abdominal pain
  - id: HP:0002014
    label: Diarrhoea
  - id: HP:0002573
    label: Rectal bleeding
  - id: HP:0000952
    label: jaundice
  - id: HP:0001878
    label: hemolytic anemia
  - id: MONDO:0005920
    label: Plasmodium falciparum malaria
  - id: CHEBI:17303
    label: Morphine
  - id: CHEBI:5855
    label: Ibuprofen
  - id: MAXO:0000457
    label: Pain management
  - id: CHEBI:16335
    label: Adenosine
  - id: CHEBI:37550
    label: S1P
  - id: HP:0002140
    label: ischemic stroke
  - id: CHEBI:9570
    label: thiotepa
  - id: MONDO:0013150
    label: Invasive Pneumococcal Disease (IPD)
  - id: HP:0031864
    label: bacteremia
  - id: HP:0011947
    label: respiratory tract infection
  - id: HP:0001139
    label: High transcranial Doppler (TCD) velocities
  - id: MONDO:0019542
    label: Acute Liver Failure
  - id: HP:0001399
    label: Hepatic failure
  - id: MONDO:0018585
    label: Childhood arterial ischemic stroke
  - id: HP:0001269
    label: Hemiparesis
  - id: HP:0002381
    label: Aphasia
  - id: HP:0011153
    label: Partial motor seizures
  - id: HP:0000822
    label: Hypertension
  - id: CHEBI:9168
    label: Sirolimus
  - id: MAXO:0000750
    label: Conditioning regimen
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0009012
    label: Intrauterine transfusions
  - id: HP:0001941
    label: acidosis
  - id: HP:0012418
    label: hypoxemia
  - id: MONDO:0006978
    label: Splenic Infarct
  - id: HP:0012223
    label: Splenic rupture
  - id: HP:0100749
    label: chest pain
  - id: HP:0002098
    label: respiratory distress
  - id: HP:0004870
    label: Chronic hemolytic anemia
  - id: MAXO:0010026
    label: zinc supplementation
  - id: MAXO:0000423
    label: skin biopsy
  - id: HP:0000988
    label: skin rash
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50858
    label: corticosteroid
  - id: HP:0010885
    label: avascular necrosis
  - id: CHEBI:28918
    label: epinephrine
  - id: HP:0003281
    label: increased serum ferritin levels
